Skip to main content
SpringerLink
Log in

Gene Therapy for Liver Tumours

  • Chapter
  • First Online:
Cancer Gene Therapy

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 465))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allgaier, H.P., Deibert, P., Becker, G., and Blum, H.E., 1998, Hepatocellular carcinoma: non-surgical treatment. Schweiz Rundsch Med Prax87:1466–1470.

    CAS  Google Scholar 

  • Anderson, W.F., 1984, Prospects for human gene therapy. Science226:401–409.

    CAS  PubMed  Google Scholar 

  • Anderson, S.C, Johnson, D.E., Harris M.P., Engler, H., Hancock, W., Huang, W.-M., Wills, K.N., Gregory, R.J., Sutjipto, S., Wen, S.F., Lofgren, S., Shepard, H.M., and Maneval, D.C., 1998, p53 Gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of recombinant adenovirus. Clin. Cancer Res.4:1649–1659.

    CAS  PubMed  Google Scholar 

  • Baba, M., Yamamoto, R., Iishi, H., and Tatsuta, M., 1997, Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by antisense sequences in rat liver. Int. J. Cancer72:815–820.

    CAS  PubMed  Google Scholar 

  • Barisani, D., Green. R.M., and Gollan, J.L., 1999, Genetic hemochromatosis: pathogenesis, diagnosis, and therapy. Dig. Dis.14(15):304–315.

    Google Scholar 

  • Bishop, J.M., 1987, The molecular genetics of cancer. Science235:305–311.

    CAS  PubMed  Google Scholar 

  • Bishop, J.M., 1986, Oncogenes and proto-oncogenes. J. Cell Physiol, suppl 4:1–5.

    Google Scholar 

  • Blumgart, L.H., and Fong, Y. 1995, Surgical options in the treament of hepatic metastases from colorectal cancer. Curr. Probl. Surg.32:333–428.

    CAS  PubMed  Google Scholar 

  • Bressac, B., Galvin, K.M., Liang, T.J., Isselbacher, K.J., Wands, J.R., and Ozturk, M., 1990, Abnormal strusture and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA87:1973–1977.

    CAS  PubMed  Google Scholar 

  • Bressac, B., Kew, M., Wands, J., and Ozturk, M., 1991, Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature350:429–431.

    CAS  PubMed  Google Scholar 

  • Carr, B.I., Flickinger, J.C., and Lotze, M.T. Hepatobiliary Cancers. In: DeVita VT, Jr. Hellman S, Rosenberg SA. eds. Cancer Principles and Practice of Oncology. 5th ed. Philadelphia: J.B. Lippincott Co., 1997:1087–1114.

    Google Scholar 

  • Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann J.L., and Klatzmann, D., 1993, Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA90:7024–7028.

    CAS  PubMed  Google Scholar 

  • Caselmann, WH., 1995, Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. J. Hepatol.21:34–37.

    Google Scholar 

  • Crystal, R.G., 1997, Phase I study of direct administration of a replication deficient adenovirus vector containing E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine. Hum. Gene Theapy8:985–1001.

    CAS  Google Scholar 

  • Curley, S.A., and Vecchio, R., 1998, New trends in the surgical treatment of colorectal cancer liver metastases. Tumori84:281–288.

    CAS  PubMed  Google Scholar 

  • Dourakis, S.P., and Tolis, G., 1998, Sex hormonal preparations and the liver. Eur. J. Contracept. Reprod. Health Care3(1):7–16.

    CAS  PubMed  Google Scholar 

  • Eagon, P.K., Elm, M.S., Epley, M.J., Shinozuka, H., and Rao, K.N., 1996, Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats. Gastroentrol110(4):1199–1207.

    CAS  Google Scholar 

  • Fellows, I.W., Stewart, M., Jeffcoate, W.J., Smith, P.G., and Toghill, P.J., 1988, Hepatocellular carcinoma in primary hemochromatosis in the abscence of cirrhosis. Gut,29, 1603–1606.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Finlay, C.A., Hinds, P.W., and Levine, A.J., 1989, The p53 proto-oncogene can act as a suppressor of transformation. Cell57(7):1083–1093.

    CAS  PubMed  Google Scholar 

  • Fong, Y., and Blumgart, L.H., 1998, Hepatic colorectal metastasis: current status of surgical therapy. Oncology12:1489–98.

    CAS  PubMed  Google Scholar 

  • Freeman, S.M. Therapeutic Applications of HSV-TK Suicide Gene. 3rd International Cancer Gene Therapy Meeting, Imperial College School of Medicine. May 1998.

    Google Scholar 

  • Freeman, S., Abboud, C., Whartenby, K.., Packman, C., Moolten, F., and Abraham, G., 1993, The “bystander effect”, tumour regression when a fraction of the tumour mass is genetically modified. Cancer Research53:5274–5283.

    CAS  PubMed  Google Scholar 

  • Gerber, M.A., 1995, Pathobiological effects of hepatitis C. J. Hepatol.22:83–86.

    CAS  PubMed  Google Scholar 

  • Gerbes, A.L., and Caselmann, W.H., 1993, Point mutations of the p53 gene, human hepatocellular carcinoma and aflatoxins. J. Hepatol.19:312–315.

    CAS  PubMed  Google Scholar 

  • Gou, Y. Cytokines and Immunotherapy. In: Mazarakis H, Swart SJ., eds. Cancer Gene Therapy. MA: IBC, 1997:155–168.

    Google Scholar 

  • Gundlach, M., Brunken, C., Broelsch, C.E., 1998, Hepatocellular carcinoma: surgical treatment. Schweiz Rundsch Med Prax87:1471–1474.

    CAS  Google Scholar 

  • Habib, N.A., Ding, S.-F., El-Masry, R., Mitry, R.R., Honda, K., Michail, N.E., Dalla Serra, G., Izzi, G., Greco, L., Bassyouni, M., El-Toukhy M., and Abdel-Gaffar, Y., 1996, Preliminary Report: The short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas. Cancer Detection and Prevention20:103–107.

    CAS  PubMed  Google Scholar 

  • Harris, M.P., Sutjipto, S., Wills, K.N., Hancock, W., Cornell, D., Johnson, D.E., Gregory, R.J., Shepard, H.M., and Maneval, D.C., 1996, Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther.3(2):121–30.

    CAS  PubMed  Google Scholar 

  • Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C., 1991, p53 Mutations in Human Cancers. Science253:49–53.

    CAS  PubMed  Google Scholar 

  • Honda, K., Sbisa, E., Tullo, A., Papeo, P.A., Saccone, C., Poole, S., Pignatelli, M., Mitry, R.R., Ding, S., Isla, A., Davies, A., and Habib, N.A., 1998, p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br. J. Cancer 1998, 77(5):776–782.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ido, A., Nakata, K., Kato, Y., Nakao, K., Murata, K., and Nagataki, S., 1995, Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res.55:3105–3109.

    CAS  PubMed  Google Scholar 

  • Jiao, R.L., Hansen, P.D., Havlik, R., Mitry, R.R., Pignatelli, M., and Habib, N.A., 1999, Clinical short-term results of radiofrequency ablation in primary and secondary liver tumours. Am. J. Surg. [Accepted].

    Google Scholar 

  • Jolly, D., 1994, Viral vector systems for gene therapy. Cancer Gene Therapy1:51–64.

    CAS  PubMed  Google Scholar 

  • Kanai, F., Hamada, H., Shiratori, Y., and Omata, M., 1997, Adenovirus-mediated enzyme-prodrug therapy for cancer. The Cancer Journal10(6) [Novermber/December].

    Google Scholar 

  • Kanai, F., Lan, K.H., Shiratori, Y., Tanaka, T., Ohashi, M., and Omata, M., 1997, In vivo gene therapy for alpha-fetoprotein—producing hepatocellular carcinoma by adenovirus-mediatd transfer of cytosine deaminase gene. Cancer Res.57(3):461–465.

    CAS  PubMed  Google Scholar 

  • Kanai, F., Shiratori, Y., Yoshida, Y., Kanegae, Y., Nakabayashi, H., and Omata, M., 1996, Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Hepatology23:1359–1367.

    CAS  PubMed  Google Scholar 

  • Kanazawa, Y. Antisense Approach. In: Mazarakis H, Swart SJ., eds. Cancer Gene Therapy. MA: IBC, 1997:223–231.

    Google Scholar 

  • Kanazawa, Y., Ohkawa, K., Ueda, K., Mita, E., Takehara, T., and Hayashi, N., 1996, Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun.225(2):570–576.

    CAS  PubMed  Google Scholar 

  • Kato, I., and Kido, C., 1987, Increased risk of death in thorotrast-exposed patients during the late follow-up period. Jpn. J. Cancer Res.78(11):1187–1192.

    CAS  PubMed  Google Scholar 

  • Kew, M.C., 1996, The hepatitis B virus and the genesis of hepatocellular carcinoma. G. I. Cancer1:143–148.

    Google Scholar 

  • Kishimoto, K., Fujimoto, J., Takeuchi, M., Yamamoto, H., Ueki, T., and Okamoto, E., 1998, Telomerase activity in hepatocellular carcinoma and adjacent liver tissues. J. Surg. Oncol.69(3):119–24. Ko, L.J., Prives, C., 1996, p53: puzzle and paradigm. Genes Dev. 10(9):1054-1072.

    CAS  PubMed  Google Scholar 

  • Kobertz, W.R., Wang, D., Wogan, G.N., and Essigmann, J.M., 1997, An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific alflatoxin B1 adducts in a p53 mutational hotspot. Proc. Natl. Acad. Sci. USA94(18):9579–9584.

    CAS  PubMed  Google Scholar 

  • Kuriyama, S., Masui, K., Sakamoto, T., Nakatani, T., Kikukawa, M., and Tsujii, T., 1998, Bystander effect caused bu cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil. Anticancer Research18(5A):3399–406.

    CAS  PubMed  Google Scholar 

  • Lane, D.P., 1992, p53, guardian of the genome. Nature358, 15–16.

    CAS  PubMed  Google Scholar 

  • Liao, Y., Tang, Z.Y., Liu K.D., Ye, S.L., and Huang, Z., 1997, Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA—in vitro and in vivo studies. J. Cancer. Res. Clin. Oncol.123(1):25–33.

    CAS  PubMed  Google Scholar 

  • Livraghi, T., Vettori, C., and Lazzaroni, S., 1991, Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology179:709–712.

    CAS  PubMed  Google Scholar 

  • Lunn, R.M., Zhang, Y.-J., Wang, L.-Y., Chen, C.-J., Lee, P.-H., Lee, C.-S., Tsai, W.Y., and Santella, R.M., 1997, p53 mutations, chronic Hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res.57:3471–3477.

    CAS  PubMed  Google Scholar 

  • Lygidakis, N.J., Kosmidis, P., Yiras, N., Parissis, J., Kyparidou, E., 1995, Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem. J Interferon Cytokine Res15:467–472.

    CAS  PubMed  Google Scholar 

  • Marone, G., Francica, G., D’Angelo, V., Iodice, G., Pastore, P., and Siani, A., 1998, Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle. Radiol Med95:624–629.

    CAS  PubMed  Google Scholar 

  • Mitry, R.R., Sarraf, C.E., Wu, C.G., Pignatelli, M., and Habib, N.A., 1997, Wild-type p53 induces apoptosis in Hep3B through up-regulation of bax expression. Lab. Invest. 1997, 77(4):369–378.

    CAS  PubMed  Google Scholar 

  • Moolten, F.L., and Wells, J.M., 1990, Curability of tumours bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst.82:297–300.

    CAS  PubMed  Google Scholar 

  • Moolten, F.L., 1986, Tumour chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res.; 46:5276–5281.

    CAS  PubMed  Google Scholar 

  • Nagashima, I., Hamada, C., and Naruse, K., 1996, Surgical resection for small hepatocellular carcinoma. Surgery119:40–45.

    CAS  PubMed  Google Scholar 

  • Nakabayashi, H., Watanabe, K., Saito, A., Otsuru, A., Sawadaishi, K., and Tamaoki, T., 1989, Transcriptional regulation of alpha-fetoprotein expression by dexamethasone in human hepatoma cells. J. Biol. Chem.264:266–271.

    CAS  PubMed  Google Scholar 

  • Oda. T., Tsuda, H., Sakamoto, M., and Hirohashi., S., 1994, Different mutations of the p53 gene in nodule-in-nodule hepatocellular carcinoma as a evidence for multistage progression. Cancer Lett.83(1–2):197–200.

    CAS  PubMed  Google Scholar 

  • Ohta, Y., Kijima, H., Ohkawa, T., Kashani-Sabet, M., and Scanlon, K.J., 1996, Tissue specific expression of an anti-ras ribozyme inhibits proliferation of human malignant cells. Nuc. Acids Res.24(5): 938–942.

    CAS  Google Scholar 

  • Olajos, E.J., 1977, Biological interactions of N-nitroso compounds: a review. Ecotoxicol. Environ. Safety 1:175–196.

    CAS  PubMed  Google Scholar 

  • Philosophe, B., Greig, P.D., Hemming, A.W., Cattral, M.S., and Langer, B., 1998, surgical management of hepatocellular carcinoma: resection or transplantation? J Gastrointestinal Surg2:21–27.

    CAS  Google Scholar 

  • Puisieux, A., Galvin, K., Troalen, F., Bressac, B., Marcais, C., Galun, E., Ponchel, F., Yakicier, C., Ji, J., and Ozturk, M., 1993a, retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J.7:1407–1413.

    CAS  PubMed  Google Scholar 

  • Puisieux, A., Ponchel, F., and Ozturk, M., 1993b, p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells. Oncogene8:487–490.

    CAS  PubMed  Google Scholar 

  • Roth, J.A., and Cristiano, R.J., 1997, Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst.89:21–39.

    CAS  Google Scholar 

  • Rougier, P., 1998, Are there indications for intraarterial hepatic chemotherapy or isolated liver perfusion? The case of liver metastases from colorectal cancer. Recent Results Cancer Res147:3–12.

    CAS  PubMed  Google Scholar 

  • Scanlon, K. Antisense Approach. In: Mazarakis H, Swart SJ., eds. Cancer Gene Therapy. MA: IBC, 1997:197–212.

    Google Scholar 

  • Scorsone, K.A., Zhou, Y.-Z., Butel, J.S., and Slagle, B.L., 1992, p53 Mutations Cluster at Codon 249 in Hepatitis B Virus-positive Hepatocellular Carcinomas from China. Cancer Res.52:1635–1638.

    CAS  PubMed  Google Scholar 

  • Seitz, H.K., Poschl, G., and Simanowski, U.A., 1998, Alcohol and cancer. Recent. Dev. Alcohol14:67–95.

    CAS  PubMed  Google Scholar 

  • Sheiner, P.A., Brower, S.T., Treatment of metastatic cancer to the liver. Sem Liver Dis 1994, 14:169–177.

    CAS  Google Scholar 

  • Sheu, J.C., Huang, G.T., Lee, P.H., Chung, J.C., Chou, H.C., Lai, M.Y., Wang, J.T., Lee, H.S., Shih, L.N., Yang, P.M., et al., 1992, Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res.52(21):6098–6100.

    CAS  PubMed  Google Scholar 

  • Solomon. E., Borrow. J., and Goddard, A.D., 1991, Chromosome aberrations and cancer. Science254:1153–1160.

    CAS  PubMed  Google Scholar 

  • Spitz, F.R., Nguyen, D., Skibber, J.M., Cusack, J., Roth, J.A., and Cristiano, R.J., 1996, In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Res.16:3415–22.

    CAS  PubMed  Google Scholar 

  • Steele, G., Standard postoperative monitoring of patients after resection of colon and rectum cancer. Cancer, 1993; 71;1993.

    Google Scholar 

  • Su, H., Chang, J., Mei Xu, S., and Wai Kan, Y., 1996, Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene. Hum. Gene Therapy7:463–470.

    CAS  Google Scholar 

  • Tabor, E., 1994, Tumor suppressor genes, growth factor genes, and oncogenes in Hepatitis B virus-associated hepatocellular carcinoma. J. Med. Virol.42:357–365.

    CAS  PubMed  Google Scholar 

  • Tahara, H., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J.W., and Ide, T., 1995, Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res.55(13):2734–6.

    CAS  PubMed  Google Scholar 

  • Tiraby, M., Cazaux, C., Baron, M., Drocourt, D., Reynes, J.P., and Tiraby, G., 1998, Concomitant expression of E.coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotxicity of 5-fluorocytosine. FEMS Microbiol. Lett.167(1):41–49.

    CAS  PubMed  Google Scholar 

  • Ueki, T., Nakata, K., Mawatara, F., Tsuruta, S., Ido, A., and Eguchi, K., 1998, Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice. Int. J. Mol. Med.1(4):671–675.

    CAS  PubMed  Google Scholar 

  • Vaughn, D.J., Haller, D.G., 1993 Nonsurgical management of recurrent colorectal cancer. Cancer, 71: 4278–4292.

    CAS  PubMed  Google Scholar 

  • Vogelstein, B., and Kinzler, K.W., 1993, The multistep nature of cancer. TIG9(4):138–141.

    CAS  PubMed  Google Scholar 

  • Wallace, H., Clarke, A.R., Harrison, D.J., Hooper, M.L., and Bishop, J.O., 1996, Ganciclovir-induced ablation non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis. Oncogene13(1):55–61.

    CAS  PubMed  Google Scholar 

  • Wands, I.R., and Blum, H.E., 1991, Primary hepatocellular carcinoma. New Engl. J. Med.325:729–731.

    CAS  PubMed  Google Scholar 

  • Wang, X.W., Gibson, M.K., Vermeulen, W., Yeh, H., Forrester, K., Stürzbecher, H.-W., Hoeijmakers, J.H.J., and Harris, C.C., 1995, Abrogation of p53-induced apoptosis by the hepatitis B vris X gene. Cancer Res.55:6012–6016.

    CAS  PubMed  Google Scholar 

  • Weinberg, R.A., 1991, Tumour suppressor genes. Science254:1138–1146.

    CAS  PubMed  Google Scholar 

  • Weisburger, E., 1977, Carcinogenicity studies on halogenated hydrocarbons. Environ. Health Perspect21:25–30.

    Google Scholar 

  • Xu GW, Sun ZT, Forrester K, Wang XW, Coursen J, Harris CC., 1996, Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene. Hepatology24(5):1264–1268.

    CAS  PubMed  Google Scholar 

  • Yotsuyanagi, H., Koike, K., Yasuda, K., Moriya, K., Hino, K., Kurokawa, K., and Iino, S., 1995, Hepatitis C Virus Genotypes and Development of Hepatocellular Carcinoma. Cancer76:1352–1355.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Surgery Section Division of Surgery Anaesthetics and Intensive Care, Imperial College School of Medicine, Hammersmith Hospital Campus Du Cane Road, London, W12 ONN, UK

    Ragai R. Mitry, Marc R. Mansour, Roman Havlik & Nagy A. Habib

Authors
  1. Ragai R. Mitry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc R. Mansour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roman Havlik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nagy A. Habib
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Imperial College School of Medicine, Hammersmith Hospital, London, UK

    Nagy A. Habib

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Mitry, R.R., Mansour, M.R., Havlik, R., Habib, N.A. (2002). Gene Therapy for Liver Tumours. In: Habib, N.A. (eds) Cancer Gene Therapy. Advances in Experimental Medicine and Biology, vol 465. Springer, New York, NY. https://doi.org/10.1007/0-306-46817-4_18

Download citation

  • DOI: https://doi.org/10.1007/0-306-46817-4_18

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-306-46191-0

  • Online ISBN: 978-0-306-46817-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation